Jae Seok Bae
Seoul National University · 医学
研究室紹介
Professor Jae Seok Bae's research lab specializes in abdominal radiology, with a primary focus on medical imaging techniques for the diagnosis and management of hepatocellular carcinoma (HCC) and liver diseases. The lab investigates the diagnostic performance of various imaging modalities—such as MRI, CT, elastography, and ultrasonography—particularly in detecting vascularity, hepatic steatosis, portal vein tumor thrombosis, and tumor thrombi in liver cancer. Their work emphasizes improving diagnostic accuracy using advanced imaging protocols and standardized reporting systems like LI-RADS and LR-TIV, with a strong translational focus on correlating imaging findings with histopathological outcomes. The lab also explores interventional radiology applications, including endoscopic balloon dilation and stent placement for gastrointestinal motility disorders.
Research Overview
Research Output Trend
Figures are computed from collected data and may differ slightly.
Selected Papers
15The sensitivity of MFI was higher than that of CDI or PDI in detecting the vascularity of HCCs when the vascular pattern was considered. MFI better detected the vascularity of shallow tumors.
PURPOSE: The present study compared the performance of computed tomography (CT), magnetic resonance imaging-derived proton density fat fraction (MRI-PDFF), controlled attenuation parameter (CAP), grayscale ultrasonography (US), and attenuation imaging (ATI) for the diagnosis of hepatic steatosis (HS). METHODS: In total, 120 prospectively recruited patients who underwent hepatic resection between June 2018 and June 2020 were retrospectively analyzed. CT, MRI-PDFF, CAP, grayscale US, and ATI were
<b><i>Introduction:</i></b> The detection of portal vein tumor thrombosis (PVTT) in patients with hepatocellular carcinoma (HCC) meeting the Milan criteria is of critical importance as PVTT is known to be a contraindication to transplantation and an indicator of a dismal prognosis. <b><i>Objective:</i></b> To determine which modality may best detect PVTT, we compared the diagnostic performance of gadoxetic acid-enhanced MRI (GA-MRI) and contrast-en
Background The Liver Imaging Reporting and Data System (LI-RADS), version 2018, treatment response algorithm (TRA) is used to assess hepatocellular carcinoma (HCC) after local-regional therapy (LRT). However, its diagnostic performance has not yet been fully compared between CT and hepatobiliary agent (HBA)-enhanced MRI in patients who have undergone liver transplant (LT). Purpose To compare the diagnostic performance of LI-RADS TRA when using CT versus using HBA-enhanced MRI in an intraindividu
Background Diagnostic performance of the Liver Imaging Reporting and Data System tumor in vein (LR-TIV) category at CT and/or MRI has not yet been evaluated, to the knowledge of the authors. Purpose To assess the diagnostic performance of the LR-TIV category in detecting macroscopic tumors in veins (TIVs) at CT and hepatobiliary contrast agent-enhanced (HBA) MRI, with pathologic results used as the reference standard. Materials and Methods Between January 2010 and December 2019, consecutive pati